Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL
Clinical trial NCT05164341 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05164341
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2026-07-21
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.